Establishes "End-Stage Kidney Disease Prevention and Innovation Act"; appropriates $10 million.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed General Assembly
- To Governor
- Became Law
Overview
This bill, the ‘End-Stage Kidney Disease Prevention and Innovation Act,’ creates a research program within the New Jersey Department of Health to study and combat rare kidney diseases. It allocates $10 million to establish Centers on Rare Kidney Disease Research, fund fellowships, and conduct a comprehensive study on testing, prevention, and treatment methods. The goal is to improve diagnosis, treatment, and awareness of these diseases, particularly in underserved communities.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Introduced
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours